C A Richards

2.3k total citations
18 papers, 1.8k citations indexed

About

C A Richards is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, C A Richards has authored 18 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Infectious Diseases. Recurrent topics in C A Richards's work include Biochemical and Molecular Research (4 papers), T-cell and Retrovirus Studies (3 papers) and Hepatitis B Virus Studies (3 papers). C A Richards is often cited by papers focused on Biochemical and Molecular Research (4 papers), T-cell and Retrovirus Studies (3 papers) and Hepatitis B Virus Studies (3 papers). C A Richards collaborates with scholars based in United States, United Kingdom and Portugal. C A Richards's co-authors include Brian E. Huber, Elizabeth A. Austin, Steven S. Good, Thomas A. Krenitsky, Stephen T. Davis, Mary E. Fling, P A Furman, M H St Clair, A J Langlois and Wayne H. Miller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

C A Richards

18 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C A Richards United States	17	810	722	433	429	326	18	1.8k
Venkatakrishna Shyamala United States	23	805 1.0×	402 0.6×	397 0.9×	770 1.8×	485 1.5×	41	2.6k
Shin Sasaki Japan	25	1.2k 1.5×	320 0.4×	252 0.6×	350 0.8×	212 0.7×	98	2.3k
Margaret Goodall United Kingdom	31	1.3k 1.6×	199 0.3×	413 1.0×	334 0.8×	216 0.7×	76	3.6k
J. Content Belgium	30	1.4k 1.7×	327 0.5×	615 1.4×	707 1.6×	661 2.0×	70	3.1k
Anuradha Chakraborti India	21	529 0.7×	181 0.3×	365 0.8×	499 1.2×	119 0.4×	98	1.7k
Eric J. Patzer United States	19	812 1.0×	130 0.2×	454 1.0×	433 1.0×	97 0.3×	24	1.9k
Timo Sareneva Finland	30	1.1k 1.3×	198 0.3×	304 0.7×	901 2.1×	692 2.1×	36	3.8k
Kenneth S. S. Chang United States	19	679 0.8×	194 0.3×	301 0.7×	287 0.7×	231 0.7×	54	1.6k
R V Srinivas United States	25	729 0.9×	297 0.4×	1.0k 2.4×	568 1.3×	501 1.5×	58	2.4k
Anne‐Marie Steffan France	22	776 1.0×	326 0.5×	307 0.7×	297 0.7×	84 0.3×	44	1.9k

Countries citing papers authored by C A Richards

Since Specialization

Citations

This map shows the geographic impact of C A Richards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C A Richards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C A Richards more than expected).

Fields of papers citing papers by C A Richards

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C A Richards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C A Richards. The network helps show where C A Richards may publish in the future.

Co-authorship network of co-authors of C A Richards

This figure shows the co-authorship network connecting the top 25 collaborators of C A Richards. A scholar is included among the top collaborators of C A Richards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C A Richards. C A Richards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

McKnight, Kevin L., Karen V. Swanson, Kathryn Austgen, et al.. (2020). Stimulator of interferon genes (STING) is an essential proviral host factor for human rhinovirus species A and C. Proceedings of the National Academy of Sciences. 117(44). 27598–27607. 29 indexed citations

Pérez‐Herrán, Esther, Mónica Cacho, Lluís Ballell, et al.. (2015). Mycobacterium tuberculosis Gyrase Inhibitors as a New Class of Antitubercular Drugs. Antimicrobial Agents and Chemotherapy. 59(4). 1868–1875. 39 indexed citations

Gentry, Daniel R., Katja Remlinger, C A Richards, et al.. (2010). A rapid microtiter plate assay for measuring the effect of compounds on Staphylococcus aureus membrane potential. Journal of Microbiological Methods. 83(2). 254–256. 24 indexed citations

Gayle, Richard B., C R Maliszewski, Steven D. Gimpel, et al.. (1998). Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39.. Journal of Clinical Investigation. 101(9). 1851–1859. 149 indexed citations

Huber, Brian E., Elizabeth A. Austin, C A Richards, Stephen T. Davis, & Steven S. Good. (1994). Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.. Proceedings of the National Academy of Sciences. 91(17). 8302–8306. 340 indexed citations

Kuramoto, I. K., et al.. (1993). Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccine. Transfusion. 33(5). 362–367. 41 indexed citations

Huber, Brian E., et al.. (1993). In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase.. PubMed. 53(19). 4619–26. 189 indexed citations

Zeldis, Jerome B., I. K. Kuramoto, C A Richards, et al.. (1992). Seroepidemiology of viral infections among intravenous drug users in northern California.. PubMed. 156(1). 30–5. 81 indexed citations

Richards, C A, et al.. (1991). Prevalence of antibody to hepatitis C virus in a blood donor population. Transfusion. 31(2). 109–113. 32 indexed citations

10.

Huber, Brian E., C A Richards, & Thomas A. Krenitsky. (1991). Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy.. Proceedings of the National Academy of Sciences. 88(18). 8039–8043. 256 indexed citations

11.

Richards, C A, Steven A. Short, Snorri S. Thorgeirsson, & Brian E. Huber. (1990). Characterization of a transforming N-ras gene in the human hepatoma cell line Hep G2: additional evidence for the importance of c-myc and ras cooperation in hepatocarcinogenesis.. PubMed. 50(5). 1521–7. 34 indexed citations

12.

Singer, Samuel, et al.. (1989). Cloning, purification, and properties of Candida albicans thymidylate synthase. Journal of Bacteriology. 171(3). 1372–1378. 26 indexed citations

13.

Fling, Mary E., et al.. (1988). Characterization of plasmid pAZ1 and the type III dihydrofolate reductase gene. Plasmid. 19(1). 30–38. 29 indexed citations

14.

Clair, M H St, C A Richards, T Spector, et al.. (1987). 3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase. Antimicrobial Agents and Chemotherapy. 31(12). 1972–1977. 250 indexed citations

15.

Elwell, Lynn P., Robert Ferone, George A. Freeman, et al.. (1987). Antibacterial activity and mechanism of action of 3'-azido-3'-deoxythymidine (BW A509U). Antimicrobial Agents and Chemotherapy. 31(2). 274–280. 128 indexed citations

16.

Richards, C A, et al.. (1985). Nucleotide sequence of the transposon Tn7 gene encoding an aminoglycoside-modifying enzyme, 3″(9)-O-nucleotidyltransferase. Nucleic Acids Research. 13(19). 7095–7106. 75 indexed citations

17.

Holland, Paul V., et al.. (1985). Anti‐HTLV‐III testing of blood donors: reproducibility and confirmability of commercial test kits. Transfusion. 25(4). 395–397. 8 indexed citations

18.

Fling, Mary E. & C A Richards. (1983). The nucleotide sequence of the trimethoprim-resistant dihydrofolate reductase gene harbored by Tn7. Nucleic Acids Research. 11(15). 5147–5158. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact